menu ☰
menu ˟

New in-office treatment addresses MGD

09 Nov 2018
SAN ANTONIO – Leslie O’Dell, OD, discussed here at the American Academy of Optometry meeting an up-and-coming product for patients with meibomian gland dysfunction (MGD), Sight Science’s Tear Care.With the in-office treatment, the eyelids are c...

Click here to view the full article which appeared in Optometry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.